Medicare Enrolled
Dr. Prakash Desai, M.D.
Cardiovascular Disease · Amarillo, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Prakash Desai is a cardiovascular disease in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Desai performed 13,978 Medicare services across 6,118 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desai received a total of $49,373 from 33 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $49,373 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,978
Medicare services
Top 2% in TX for cardiovascular disease
6,118
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~699 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 1,616 | $19 | $76 |
| Electrocardiogram (EKG), 12-lead | 1,478 | $10 | $61 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,368 | $28 | $74 |
| Contrast dye for imaging (iodine-based) | 1,265 | $0 | $2 |
| Office visit, established patient (30-39 min) | 1,223 | $93 | $258 |
| Remote pacemaker/defibrillator monitoring, 90 days | 1,222 | $16 | $56 |
| EKG interpretation and report | 750 | $6 | $44 |
| Remote pacemaker monitoring, 90 days | 713 | $21 | $96 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 602 | $19 | $68 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 511 | $26 | $153 |
| Anticoagulant management of patient taking warfarin | 484 | $8 | $34 |
| Chronic care management, first 20 min/month | 341 | $32 | $100 |
| Hospital follow-up visit, moderate complexity | 318 | $62 | $159 |
| Programming of dual lead pacemaker system | 287 | $58 | $201 |
| Ultrasound of both sides of head and neck blood flow | 129 | $78 | $273 |
| Prothrombin time test (blood clotting) | 120 | $4 | $32 |
| Office visit, established patient, complex (40-54 min) | 118 | $132 | $359 |
| Echocardiogram, transthoracic | 116 | $132 | $909 |
| Initial hospital admission, moderate complexity | 108 | $99 | $274 |
| Office visit, established patient (20-29 min) | 105 | $64 | $180 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $138 | $436 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 79 | $19 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system | 68 | $30 | $200 |
| Programming of dual lead implantable defibrillator system | 67 | $72 | $217 |
| Cardiac catheterization | 66 | $219 | $1,159 |
| Programming of multiple lead implantable defibrillator system | 59 | $80 | $220 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 58 | $197 | $522 |
| Ultrasound of leg arteries or artery grafts | 50 | $100 | $338 |
| Programming of single lead implantable defibrillator system | 44 | $51 | $179 |
| Remote patient monitoring device, 30 days | 38 | $25 | $180 |
| Evaluation of cardiac rhythm monitor system | 35 | $34 | $122 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $10 | $76 |
| Ultrasound of heart, follow-up | 33 | $18 | $163 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 31 | $399 | $1,456 |
| Repair of left upper heart chamber with implant with review by radiologist | 31 | $603 | $1,612 |
| Initial hospital admission, high complexity | 31 | $134 | $370 |
| Hospital discharge day management, 30 minutes or less | 31 | $64 | $162 |
| New patient office visit (45-59 min) | 29 | $125 | $320 |
| Hospital follow-up visit, high complexity | 29 | $85 | $226 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 23 | $8 | $150 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 23 | $15 | $150 |
| Injection for imaging of aorta above heart valve with review by radiologist | 23 | $28 | $88 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 22 | $124 | $874 |
| Removal of heart rhythm monitor from under the skin | 21 | $46 | $676 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $93 | $394 |
| Ultrasound study of arm and leg arteries | 20 | $34 | $241 |
| Insertion of heart rhythm monitor under skin | 18 | $67 | $2,827 |
| Insertion of implantable defibrillator system | 17 | $698 | $2,362 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 12 | $6 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $615 | $1,583 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.8% high complexity
11.4% medium
65.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$49,373
Total received (2018-2024)
Avg $7,053/year across 7 years
Top 11% in TX for cardiovascular disease
33
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$48,670 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$702 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,083
2023$7,062
2022$8,033
2021$3,743
2020$1,517
2019$5,023
2018$19,911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTRONIK INC.
$20,810
Abbott Laboratories
$10,635
Medtronic Vascular, Inc.
$4,872
Penumbra, Inc.
$4,129
Boston Scientific Corporation
$1,862
AstraZeneca Pharmaceuticals LP
$986
Biosense Webster, Inc.
$872
ABIOMED
$705
CryoLife, Inc.
$680
Medical Device Business Services, Inc.
$583
Medtronic, Inc.
$454
Boehringer Ingelheim Pharmaceuticals, Inc.
$372
CVRx, Inc.
$350
Janssen Pharmaceuticals, Inc
$223
Amgen Inc.
$177
ShockWave Medical, Inc
$168
AtriCure, Inc.
$165
PFIZER INC.
$162
Novartis Pharmaceuticals Corporation
$159
Shockwave Medical, Inc
$153
Artivion, Inc.
$144
E.R. Squibb & Sons, L.L.C.
$141
Terumo Medical Corporation
$108
Philips Electronics North America Corporation
$97
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$88
Lexicon Pharmaceuticals, Inc.
$73
Actelion Pharmaceuticals US, Inc.
$46
Merck Sharp & Dohme LLC
$37
Gilead Sciences, Inc.
$36
SANOFI-AVENTIS U.S. LLC
$34
AngioDynamics, Inc.
$21
SCPHARMACEUTICALS INC.
$19
Braemar Manufacturing, LLC
$12
Top 3 companies account for 73.6% of total payments
Associated products mentioned in payments ›
(9278) Bridge · (9520) IGT Devices Und · ATRICURE SYNERGY ABLATION SYSTEM · AVEIR · Acticor · Advisor Catheter · Allure CRT Pacemaker · Amplia MRI · Assurity Pacemaker · Attain · BIOMONITOR · BRILINTA · Barostim Neo System · BioMonitor · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 · Carto 3 System · Carto Smarttouch · CartoSound · ClosureFast · Confidense · Confirm Rx · Connectivity and Remote care · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edora 8 DR-T · Endurity Pacemaker · FARXIGA · FUROSCIX · GALLANT · General - Vascular Intervention · HawkOne · HeartMate · Impella · Indigo System · JARDIANCE · JOT DX · LEQVIO · LifeVest · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER · OPSUMIT · On-X · Optitorque · PAMIRA · PENTARAY · PERCLOSE PROGLIDE · PRO-Kinetic Energy · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · SQ-RX PULSE GENERATOR · SelectSecure · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VERQUVO · VERSASEAL · VYNDAQEL · Vascular Lithotripsy · VersaCross Access Solution · VersaCross Steerable Access Solution · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $353 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
24
Per 100K population
20.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desai is a remote & electrophysiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days?
Based on Medicare claims data, Dr. Desai performed 1,616 evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $49,373 from 33 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other cardiovascular diseases in Amarillo?
Dr. Desai's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Amarillo
Browse cardiovascular diseases in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology